CIO - Centro de Inmuno-Oncología de Occidente

Guadalajara 44630

1 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Studies at this site

• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling